Suchergebnisse - "Stoll, Paul"

PubPharm (8)

1

Dupilumab treatment increases transitional B cells in severe asthma

enthalten in: Allergy | 2023

von Lommatzsch, M. | Dost, M. | Jaishankar, N. | +4

2

Type 2 biomarker expression (FeNO and blood eosinophils) is higher in severe adult-onset than in severe early-onset asthma

enthalten in: Allergy | 2021

von Lommatzsch, M. | Klein, M. | Stoll, P. | +1

3

Eosinophilic pleural effusion and stroke with cutaneous vasculitis : Two cases of dupilumab-induced hypereosinophilia

enthalten in: Allergy | 2021

von Lommatzsch, M. | Stoll, P. | Winkler, J. | +4

4

Benralizumab strongly reduces blood basophils in severe eosinophilic asthma

enthalten in: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology | 2020

von Lommatzsch, M. | Marchewski, H. | Schwefel, G. | +3

5

COVID-19 in a patient with severe asthma treated with Omalizumab

enthalten in: Allergy | 2020

von Lommatzsch, M. | Stoll, P. | Virchow, J.

6

Neoadjuvant PD-1 Blockade in Resectable Lung Cancer

enthalten in: The New England journal of medicine | 2018

von Lommatzsch, M. | Bratke, K. | Stoll, P.

CommentOn: N Engl J Med. 2018 May 24;378(21):1976-1986. - PMID 29658848

7

Response to "obesity paradox in chronic obstructive pulmonary disease : A result of airflow obstruction over-grading?"

enthalten in: Respiratory medicine | 2017

von Lommatzsch, M. | Stoll, P.

CommentOn: Respir Med. 2016 Jul;116:59-62. - PMID 27296822

8

Postpartum venous thromboembolism

enthalten in: The New England journal of medicine | 2009

von Stoll, P. | Virchow, J. | Lommatzsch, M.

CommentOn: N Engl J Med. 2008 Dec 18;359(25):2706. - PMID 19092155

1
[1]